{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T17:13:38Z","timestamp":1793121218574,"version":"4.5.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T00:00:00Z","timestamp":1657152000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T00:00:00Z","timestamp":1657152000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA046934"],"award-info":[{"award-number":["P30CA046934"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cytogenet"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>21q22 amplification is a rare cytogenetic aberration in acute myeloid leukemia (AML). So far, the cytogenomic and molecular features and clinical correlation of 21q22 amplification in AML have not been well-characterized.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>Here, we describe a case series of three AML patients with amplified 21q22 identified by fluorescence in situ hybridization using a <jats:italic>RUNX1<\/jats:italic> probe. Two of these patients presented with therapy-related AML (t-AML) secondary to chemotherapy, while the third had de novo AML. There was one case each of FAB M0, M1 and M4. Morphologic evidence of dysplasia was identified in both t-AML cases. Phenotypic abnormalities of the myeloblasts were frequently observed. Extra copies of 21q22 were present on chromosome 21 and at least one other chromosome in two cases. Two showed a highly complex karyotype. Microarray analysis of 21q22 amplification in one case demonstrated alternating levels of high copy number gain split within the <jats:italic>RUNX1<\/jats:italic> locus at 21q22. The same patient also had mutated <jats:italic>TP53<\/jats:italic>. Two patients died at 1.5 and 11\u00a0months post-treatment, while the third elected palliative care and died within 2\u00a0weeks.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our results provide further evidence that 21q22 amplification in AML is associated with complex karyotypes, <jats:italic>TP53<\/jats:italic> aberrations, and poor outcomes. Furthermore, we demonstrate that 21q22 amplification is not always intrachromosomally localized to chromosome 21 and could be a result of structural aberrations involving 21q22 and other chromosomes.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13039-022-00606-0","type":"journal-article","created":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T21:03:18Z","timestamp":1657227798000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["21q22 amplification detection in three patients with acute myeloid leukemia: cytogenomic profiling and literature review"],"prefix":"10.1186","volume":"15","author":[{"given":"Emily M.","family":"Kudalkar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changlee","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary M.","family":"Haag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Pollyea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manali","family":"Kamdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Billie","family":"Carstens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Swisshelm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liming","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,7]]},"reference":[{"issue":"23","key":"606_CR1","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","volume":"374","author":"E Papaemmanuil","year":"2016","unstructured":"Papaemmanuil E, Gerstung M, Bullinger L, Gaidzik VI, Paschka P, Roberts ND, et al. Genomic classification and prognosis in acute myeloid leukemia. N Engl J Med. 2016;374(23):2209\u201321.","journal-title":"N Engl J Med"},{"issue":"4","key":"606_CR2","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","volume":"129","author":"H Dohner","year":"2017","unstructured":"Dohner H, Estey E, Grimwade D, Amadori S, Appelbaum FR, Buchner T, et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood. 2017;129(4):424\u201347.","journal-title":"Blood"},{"issue":"7","key":"606_CR3","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1182\/blood.V92.7.2322","volume":"92","author":"D Grimwade","year":"1998","unstructured":"Grimwade D, Walker H, Oliver F, Wheatley K, Harrison C, Harrison G, et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children\u2019s Leukaemia Working Parties. Blood. 1998;92(7):2322\u201333.","journal-title":"Blood"},{"key":"606_CR4","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.blre.2019.04.005","volume":"36","author":"RM Shallis","year":"2019","unstructured":"Shallis RM, Wang R, Davidoff A, Ma X, Zeidan AM. Epidemiology of acute myeloid leukemia: recent progress and enduring challenges. Blood Rev. 2019;36:70\u201387.","journal-title":"Blood Rev"},{"issue":"1","key":"606_CR5","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/ajh.20151","volume":"77","author":"L Thomas","year":"2004","unstructured":"Thomas L, Stamberg J, Gojo I, Ning Y, Rapoport AP. Double minute chromosomes in monoblastic (M5) and myeloblastic (M2) acute myeloid leukemia: two case reports and a review of literature. Am J Hematol. 2004;77(1):55\u201361.","journal-title":"Am J Hematol"},{"issue":"1","key":"606_CR6","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.humpath.2014.09.008","volume":"46","author":"G Tang","year":"2015","unstructured":"Tang G, DiNardo C, Zhang L, Ravandi F, Khoury JD, Huh YO, et al. MLL gene amplification in acute myeloid leukemia and myelodysplastic syndromes is associated with characteristic clinicopathological findings and TP53 gene mutation. Hum Pathol. 2015;46(1):65\u201373.","journal-title":"Hum Pathol"},{"issue":"1","key":"606_CR7","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/S0165-4608(00)00318-6","volume":"124","author":"B Streubel","year":"2001","unstructured":"Streubel B, Valent P, Lechner K, Fonatsch C. Amplification of the AML1(CBFA2) gene on ring chromosomes in a patient with acute myeloid leukemia and a constitutional ring chromosome 21. Cancer Genet Cytogenet. 2001;124(1):42\u20136.","journal-title":"Cancer Genet Cytogenet"},{"issue":"2","key":"606_CR8","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/sj.leu.2403612","volume":"19","author":"MK Andersen","year":"2005","unstructured":"Andersen MK, Christiansen DH, Pedersen-Bjergaard J. Amplification or duplication of chromosome band 21q22 with multiple copies of the AML1 gene and mutation of the TP53 gene in therapy-related MDS and AML. Leukemia. 2005;19(2):197\u2013200.","journal-title":"Leukemia"},{"issue":"4","key":"606_CR9","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1002\/hon.2287","volume":"35","author":"S Burillo-Sanz","year":"2017","unstructured":"Burillo-Sanz S, Vargas MT, Morales-Camacho RM, Caballero-Velazquez T, Sanchez J, Garcia-Lozano JR, et al. RUNX1 amplification in AML with myelodysplasia-related changes and ring 21 chromosomes. Hematol Oncol. 2017;35(4):894\u20139.","journal-title":"Hematol Oncol"},{"key":"606_CR10","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.cancergen.2021.02.004","volume":"254\u2013255","author":"H Jain","year":"2021","unstructured":"Jain H, Shetty D, Roy Moulik N, Narula G, Subramanian PG, Banavali S. A novel case of intrachromosomal amplification and insertion of RUNX1 on derivative chromosome 2 in pediatric AML. Cancer Genet. 2021;254\u2013255:65\u20139.","journal-title":"Cancer Genet"},{"issue":"1","key":"606_CR11","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.cancergencyto.2008.10.001","volume":"189","author":"SA Moosavi","year":"2009","unstructured":"Moosavi SA, Sanchez J, Adeyinka A. Marker chromosomes are a significant mechanism of high-level RUNX1 gene amplification in hematologic malignancies. Cancer Genet Cytogenet. 2009;189(1):24\u20138.","journal-title":"Cancer Genet Cytogenet"},{"key":"606_CR12","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.cancergen.2019.07.006","volume":"238","author":"D Nguyen","year":"2019","unstructured":"Nguyen D, Li Y, Safah H, Brown TC. RUNX1 deletion\/amplification in therapy-related acute myeloid leukemia: a case report and review of the literature. Cancer Genet. 2019;238:37\u201343.","journal-title":"Cancer Genet"},{"issue":"2","key":"606_CR13","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1002\/gcc.22321","volume":"55","author":"S Weber","year":"2016","unstructured":"Weber S, Haferlach C, Jeromin S, Nadarajah N, Dicker F, Noel L, et al. Gain of chromosome 21 or amplification of chromosome arm 21q is one mechanism for increased ERG expression in acute myeloid leukemia. Genes Chromosomes Cancer. 2016;55(2):148\u201357.","journal-title":"Genes Chromosomes Cancer"},{"issue":"7","key":"606_CR14","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1038\/s41379-020-0494-3","volume":"33","author":"W Xie","year":"2020","unstructured":"Xie W, Xu J, Hu S, Li S, Wang W, Cameron Yin C, et al. iAMP21 in acute myeloid leukemia is associated with complex karyotype, TP53 mutation and dismal outcome. Mod Pathol. 2020;33(7):1389\u201397.","journal-title":"Mod Pathol"},{"key":"606_CR15","doi-asserted-by":"crossref","unstructured":"Arsham MS, Barch MJ, Lawce HJ. The AGT cytogenetics laboratory manual, 4th edn. Hoboken: Wiley-Blackwell; 2017. 1 online resource p.","DOI":"10.1002\/9781119061199"},{"key":"606_CR16","doi-asserted-by":"crossref","unstructured":"McGowan-Jordan J SAaSM. ISCN 2016: an international system for human cytogenomic nomenclature: Basel: Karger; 2016.","DOI":"10.1159\/isbn.978-3-318-05979-3"},{"issue":"1","key":"606_CR17","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jmoldx.2016.10.002","volume":"19","author":"MM Li","year":"2017","unstructured":"Li MM, Datto M, Duncavage EJ, Kulkarni S, Lindeman NI, Roy S, et al. Standards and guidelines for the interpretation and reporting of sequence variants in cancer: a joint consensus recommendation of the association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists. J Mol Diagn. 2017;19(1):4\u201323.","journal-title":"J Mol Diagn"},{"issue":"7","key":"606_CR18","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/ni.1617","volume":"9","author":"SJ Loughran","year":"2008","unstructured":"Loughran SJ, Kruse EA, Hacking DF, de Graaf CA, Hyland CD, Willson TA, et al. The transcription factor Erg is essential for definitive hematopoiesis and the function of adult hematopoietic stem cells. Nat Immunol. 2008;9(7):810\u20139.","journal-title":"Nat Immunol"},{"issue":"36","key":"606_CR19","doi-asserted-by":"publisher","first-page":"9234","DOI":"10.1200\/JCO.2005.03.6137","volume":"23","author":"G Marcucci","year":"2005","unstructured":"Marcucci G, Baldus CD, Ruppert AS, Radmacher MD, Mrozek K, Whitman SP, et al. Overexpression of the ETS-related gene, ERG, predicts a worse outcome in acute myeloid leukemia with normal karyotype: a Cancer and Leukemia Group B study. J Clin Oncol. 2005;23(36):9234\u201342.","journal-title":"J Clin Oncol"},{"issue":"22","key":"606_CR20","doi-asserted-by":"publisher","first-page":"3337","DOI":"10.1200\/JCO.2007.10.8720","volume":"25","author":"G Marcucci","year":"2007","unstructured":"Marcucci G, Maharry K, Whitman SP, Vukosavljevic T, Paschka P, Langer C, et al. High expression levels of the ETS-related gene, ERG, predict adverse outcome and improve molecular risk-based classification of cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B Study. J Clin Oncol. 2007;25(22):3337\u201343.","journal-title":"J Clin Oncol"},{"issue":"38","key":"606_CR21","doi-asserted-by":"publisher","first-page":"15437","DOI":"10.1073\/pnas.1213454109","volume":"109","author":"CL Carmichael","year":"2012","unstructured":"Carmichael CL, Metcalf D, Henley KJ, Kruse EA, Di Rago L, Mifsud S, et al. Hematopoietic overexpression of the transcription factor Erg induces lymphoid and erythro megakaryocytic leukemia. Proc Natl Acad Sci U S A. 2012;109(38):15437\u201342.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"15","key":"606_CR22","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1182\/blood-2016-10-687830","volume":"129","author":"R Sood","year":"2017","unstructured":"Sood R, Kamikubo Y, Liu P. Role of RUNX1 in hematological malignancies. Blood. 2017;129(15):2070\u201382.","journal-title":"Blood"},{"issue":"1","key":"606_CR23","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.3324\/haematol.2017.180497","volume":"103","author":"FG Rucker","year":"2018","unstructured":"Rucker FG, Dolnik A, Blatte TJ, Teleanu V, Ernst A, Thol F, et al. Chromothripsis is linked to TP53 alteration, cell cycle impairment, and dismal outcome in acute myeloid leukemia with complex karyotype. Haematologica. 2018;103(1):e17\u201320.","journal-title":"Haematologica"},{"issue":"9","key":"606_CR24","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1182\/blood-2011-08-375758","volume":"119","author":"FG Rucker","year":"2012","unstructured":"Rucker FG, Schlenk RF, Bullinger L, Kayser S, Teleanu V, Kett H, et al. TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome. Blood. 2012;119(9):2114\u201321.","journal-title":"Blood"},{"issue":"3","key":"606_CR25","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/leu.2016.263","volume":"31","author":"A Stengel","year":"2017","unstructured":"Stengel A, Kern W, Haferlach T, Meggendorfer M, Fasan A, Haferlach C. The impact of TP53 mutations and TP53 deletions on survival varies between AML, ALL, MDS and CLL: an analysis of 3307 cases. Leukemia. 2017;31(3):705\u201311.","journal-title":"Leukemia"}],"container-title":["Molecular Cytogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13039-022-00606-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13039-022-00606-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13039-022-00606-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T21:03:49Z","timestamp":1657227829000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularcytogenetics.biomedcentral.com\/articles\/10.1186\/s13039-022-00606-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,7]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["606"],"URL":"https:\/\/doi.org\/10.1186\/s13039-022-00606-0","relation":{},"ISSN":["1755-8166"],"issn-type":[{"value":"1755-8166","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,7]]},"assertion":[{"value":"6 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Colorado Multiple Institutional Review Board in accordance with the Declaration of Helsinki. The Colorado Multiple Institutional Review Board has determined this as a chart review case study and granted wavier of informed consent based on its policy.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Emily M. Kudalkar, Changlee Pang, Mary M. Haag, Daniel A. Pollyea, Gang Xu, Billie Carstens, Karen Swisshelm and Liming Bao declare they have no competing interests. \nManali Kamdar reports research funding from TG Therapeutics, Genentech, Novartis; \nConsultancy from AbbVie, AstraZeneca, Celgene\/ Bristol-Myers Squibb, Adaptive Biotechnologies, ADC therapeutics, Beigene; Speaker's bureau for SeaGen and DMC for Celgene, Genentech. Meng Su is currently a salaried employee of Sema4 OpCo, Inc.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"30"}}